Van Hulzen Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.66M | Buy |
34,039
+39
| +0.1% | +$3.05K | 0.22% | 83 |
|
|
2025
Q1 | $2.46M | Sell |
34,000
-132
| -0.4% | -$9.57K | 0.22% | 86 |
|
|
2024
Q4 | $2.53M | Buy |
34,132
+132
| +0.4% | +$9.77K | 0.18% | 97 |
|
|
2024
Q3 | $2.24M | Hold |
34,000
| – | – | 0.16% | 104 |
|
|
2024
Q2 | $3.14M | Sell |
34,000
-2,110
| -6% | -$195K | 0.21% | 78 |
|
|
2024
Q1 | $3.45M | Buy |
36,110
+110
| +0.3% | +$10.5K | 0.23% | 82 |
|
|
2023
Q4 | $2.75M | Hold |
36,000
| – | – | 0.19% | 86 |
|
|
2023
Q3 | $2.49M | Hold |
36,000
| – | – | 0.19% | 86 |
|
|
2023
Q2 | $3.4M | Hold |
36,000
| – | – | 0.29% | 70 |
|
|
2023
Q1 | $2.98M | Sell |
36,000
-80
| -0.2% | -$6.62K | 0.28% | 71 |
|
|
2022
Q4 | $2.69M | Sell |
36,080
-400
| -1% | -$29.8K | 0.31% | 71 |
|
|
2022
Q3 | $3.01M | Sell |
36,480
-300
| -0.8% | -$24.8K | 0.37% | 67 |
|
|
2022
Q2 | $3.5M | Buy |
36,780
+80
| +0.2% | +$7.61K | 0.42% | 64 |
|
|
2022
Q1 | $4.32M | Hold |
36,700
| – | – | 0.46% | 61 |
|
|
2021
Q4 | $4.75M | Buy |
+36,700
| New | +$4.75M | 0.52% | 55 |
|